Oe. Offiong et S. Martelli, STEREOCHEMISTRY AND ANTITUMOR-ACTIVITY OF PLATINUM METAL-COMPLEXES OF2-ACETYLPYRIDINE THIOSEMICARBAZONES, Transition metal chemistry, 22(3), 1997, pp. 263-269
Complexes, [M(HL)(2)], where M = Pd-II, Pt-II and HL = neutral 2-acety
lpyridine-(2-methylthiosemicarbazone), 2-acetylpyridine-(4-methylthios
emicarbazone) and 2-acetylpyridine-(4-phenylthiosemicarbazone) as well
as [M(HL)(2)]Cl-3, where M Ru-III, Rh-III and Ir-III, have been prepa
red and characterized by elemental analyses, conductivity measurements
, magnetic susceptibility measurements and spectroscopic (i.r., Raman,
u.v.-vis. and H-1 and C-13-n.m.r) studies. The ligands behave as neut
ral bidentate components in the Pd-II and Pt-II complexes, whereas in
Ru-III, Rh-III and Ir-III complexes the ligands exist as neutral tride
ntates. Various ligand and nephelauxetic parameters have been calculat
ed :br the metal complexes. The Ru-III, Rh-III and Ir-III complexes ar
e six-coordinate distorted octahedral, whereas Pd-II and Pt-II are fou
r coordinated. The ligands and their platinum group complexes exhibit
a potent cytotoxic activity against Ehrlich ascites tumour cells in vi
tro but appear to be more in vivo.